Thanks @Lopez. In highlighting the FDA’s collaborative approach in the latest announcement, the company might have tried to sound ironic, but I think equally it was trying to emphasise why it had “a high level of confidence” to refile their BLA. The journey was tortuous and torturous, but having now got to a whisker within the destination with what I would describe as an unassailable moat in their understanding of the regulatory requirement, it simply solidifies their position vis a vis competitors. The challenge now is to maintain it and capitalise it for other indications. As Tony Boyd noted in the AFR not long ago, a ton of R&D had gone into the business. We cian say a lot about big pharmas, the dilutive capital raisings and the narrow shareholder base, but I look forward to the possibility that one day, maybe the optionality will be so large and the businesses so cash generative that no takeover offers would be as good as a buyback on its menu of options. When I used to be a CSL shareholder, I was told at one point during an Investor Day presentation by the company that it had not contemplated a share split because there had not been a clamour for it by its predominantly retail shareholder base. That is an interesting thought.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-391
-
-
- There are more pages in this discussion • 702 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
99.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 962 | $1.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 3941 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 162382 | 0.990 |
9 | 73573 | 0.985 |
12 | 170650 | 0.980 |
11 | 128335 | 0.975 |
13 | 267300 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 47682 | 2 |
1.000 | 51020 | 9 |
1.005 | 81648 | 8 |
1.010 | 76302 | 8 |
1.015 | 37691 | 2 |
Last trade - 09.59am 01/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online